[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337459-105":59,"doc-detail-337459-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","sox2-expression-does-not-guarantee-cancer-stem-cell-like-characteristics-in-lung-adenocarcinoma","SOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma","","Effectively targeting cancer stemness is essential for successful cancer therapy. Recent studies indicate SOX2, a pluripotent stem cell factor, contributes to cancer stem cell (CSC)-like traits linked to malignancy. Yet its effects on survival vary across cancer types, including lung adenocarcinoma (LUAD). Here, SOX2 knockout in A549, H358, and HCC827 LUAD cells using CRISPR/Cas9 leaves CSC traits such as proliferation, sphere formation, invasion, migration, and therapy resistance unchanged, while SOX2 knockdown reduces them, without rescue by shRNA-resistant SOX2.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sox2-expression-does-not-guarantee-cancer-stem-cell-like-characteristics-in-lung-adenocarcinoma/337459/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sox2-expression-does-not-guarantee-cancer-stem-cell-like-characteristics-in-lung-adenocarcinoma/337459.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main conclusion about SOX2 in lung adenocarcinoma (LUAD)?","Question",{"text":112,"@type":113},"SOX2 is not universally required for regulating CSC-like properties in LUAD, based on unchanged CSC traits after SOX2 knockout.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were SOX2 loss-of-function experiments performed in LUAD cells?",{"text":117,"@type":113},"SOX2 knockouts were generated in A549, H358, and HCC827 cells using CRISPR/Cas9, and SOX2 knockdown was performed using conditional shRNA targeting SOX2.",{"name":119,"@type":110,"acceptedAnswer":120},"Do SOX2 knockdown effects get rescued by shRNA-resistant SOX2?",{"text":121,"@type":113},"No. The loss-of-function effects from SOX2 knockdown were not rescued by SOX2 resistant to shRNA.",{"name":123,"@type":110,"acceptedAnswer":124},"Why do the authors emphasize context-dependent targeting of SOX2?",{"text":125,"@type":113},"Because prior results may depend on cancer subtype and experimental context, and SOX2 protein-level independence is suggested by the lack of rescue and the differing outcomes between knockout and knockdown.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},337459,1790141671,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","cells  \nArticle  \nSOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma  \nSeung-Hyun Bae 1,2,†, Kyung Yong Lee 2,3,†, Suji Han 1, Chul Won Yun 1, ChanHyeok Park 1,2 and Hyonchol Jang 1,2, *  \nCitation: Bae, S.-H.; Lee, K.Y.; Han, S.; Yun, C.W.; Park, C.; Jang, H. SOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma. Cells 2024, 13, 216. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cells13030216  \nAcademic Editor: Fabrizio Marcucci  \nReceived: 17 November 2023  \nRevised: 18 January 2024  \nAccepted: 22 January 2024  \nPublished: 24 January 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea; [bsh8918@ncc.re.kr](bsh8918@ncc.re.kr) (S.-H.B.)  \n2 Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea; [kylee@ncc.re.kr](kylee@ncc.re.kr)  \n3 Division of Cancer Biology, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea  \n* [Correspondence: hjang@ncc.re.kr](Correspondence: hjang@ncc.re.kr); Tel.: +82-31-920-2239 † These authors contributed equally to this work.  \nAbstract: Effectively targeting cancer stemness is essential for successful cancer therapy. Recent studies have revealed that SOX2, a pluripotent stem cell factor, significantly contributes to cancer stem cell (CSC)-like characteristics closely associated with cancer malignancy. However, its contradictory impact on patient survival in specific cancer types, including lung adenocarcinoma (LUAD), underscores the need for more comprehensive research to clarify its functional effect on cancer stemness. In this study, we demonstrate that SOX2 is not universally required for the regulation of CSC-like properties in LUAD. We generated SOX2 knockouts in A549, H358, and HCC827 LUAD cells using the CRISPR/Cas9 system. Our results reveal unchanged CSC characteristics, including sustained proliferation, tumor sphere formation, invasion, migration, and therapy resistance, compared to normal cells. Conversely, SOX2 knockdown using conditional shRNA targeting SOX2, significantly reduced CSC traits. However, these loss-of-function effects were not rescued by SOX2 resistant to shRNA, underscoring the potential for SOX2 protein level-independent results in prior siRNA-or shRNAbased research. Ultimately, our findings demonstrate that SOX2 is not absolutely essential in LUAD cancer cells. This emphasizes the necessity of considering cancer subtype-dependent and contextdependent factors when targeting SOX2 overexpression as a potential therapeutic vulnerability in diverse cancers.  \nKeywords: SOX2; cancer stem cell-like properties; CRISPR/Cas9; shRNA; lung adenocarcinoma  \n1. Introduction  \nCancer stem cells (CSCs) are implicated in tumor progression, metastatic spread, and drug resistance [1,2] . These specialized cells play critical roles in tumor heterogeneity and in developing resistance to cancer treatment by influencing CSC-like properties such as growth, invasion, stemness, and therapy response across a wide range of cancer types [3–6] . Therefore, identifying key regulators of CSC-like properties provides opportunities to understand new mechanisms of cancer treatment.  \nSOX2 (sex-determining region Y-box 2) was initially discovered as a transcription factor, playing an important role in maintaining the stemness of embryonic stem cells and inducing the transition of non-pluripotent cells to pluripotent stem cells [7,8] . Recent studies, ","cbCaii7ryYiPP5PR","https://ap.wps.com/l/cbCaii7ryYiPP5PR","pdf",4050601,15,"English","# Abstract\n# Introduction\n## Cancer stem cells and CSC-like properties\n## SOX2 in stemness and cancer\n## Contradictory roles of SOX2 across cancer types\n## Lung cancer subtypes and LUAD context","[{\"question\":\"What is the main conclusion about SOX2 in lung adenocarcinoma (LUAD)?\",\"answer\":\"SOX2 is not universally required for regulating CSC-like properties in LUAD, based on unchanged CSC traits after SOX2 knockout.\"},{\"question\":\"How were SOX2 loss-of-function experiments performed in LUAD cells?\",\"answer\":\"SOX2 knockouts were generated in A549, H358, and HCC827 cells using CRISPR/Cas9, and SOX2 knockdown was performed using conditional shRNA targeting SOX2.\"},{\"question\":\"Do SOX2 knockdown effects get rescued by shRNA-resistant SOX2?\",\"answer\":\"No. The loss-of-function effects from SOX2 knockdown were not rescued by SOX2 resistant to shRNA.\"},{\"question\":\"Why do the authors emphasize context-dependent targeting of SOX2?\",\"answer\":\"Because prior results may depend on cancer subtype and experimental context, and SOX2 protein-level independence is suggested by the lack of rescue and the differing outcomes between knockout and knockdown.\"}]","SOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma | PDF",1790019229,38,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e195cef142a43cba268d813932e53a22.webp",983,1390,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11a31cecb38d7525bda7ff5d4e3c6b53.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0999dccb1df93ee6721f8b4d38905494.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/155f729c7c50d8926aeb6300bf1de415.webp",980,1385]